United Therapeutics continues to underperform Gilead by 7.6% year to date

Media coverage

• Title	United Therapeutics continues to underperform Gilead by 7.6% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	18/02/25
  Persons	Jeffrey Klein

• Title	United Therapeutics continues to underperform Alnylam Pharmaceuticals by 4.0% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	18/02/25
  Persons	Jeffrey Klein

• Title	United Therapeutics continues to underperform Amgen by 6.7% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	18/02/25
  Persons	Jeffrey Klein

• Title	United Therapeutics continues to outperform Regeneron by 10.5% year to date
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	18/02/25
  Persons	Jeffrey Klein

• Title	United Therapeutics's Earnings Growth Outperforms Regeneron
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	18/02/25
  Persons	Jeffrey Klein

• Title	United Therapeutics's Earnings Growth Lags Gilead
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	18/02/25
  Persons	Jeffrey Klein

• Title	United Therapeutics's Earnings Growth Outperforms Amgen
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	18/02/25
  Persons	Jeffrey Klein

• Title	The Long-Term Bullish Case For United Therapeutics
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	18/02/25
  Persons	Jeffrey Klein